Surgery Partners (SGRY) Set to Announce Earnings on Tuesday

Surgery Partners (NASDAQ:SGRY - Get Free Report) is scheduled to release its earnings data before the market opens on Tuesday, May 7th. Analysts expect Surgery Partners to post earnings of $0.07 per share for the quarter. Persons interested in registering for the company's earnings conference call can do so using this link.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last released its quarterly earnings data on Monday, February 26th. The company reported $0.44 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.07. Surgery Partners had a positive return on equity of 3.65% and a negative net margin of 0.43%. The business had revenue of $735.40 million during the quarter, compared to analysts' expectations of $741.93 million. During the same quarter last year, the business posted $0.22 EPS. The business's revenue was up 4.0% on a year-over-year basis. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Trading Up 0.8 %

NASDAQ SGRY traded up $0.19 on Tuesday, hitting $24.95. The company's stock had a trading volume of 807,942 shares, compared to its average volume of 891,796. Surgery Partners has a 52-week low of $22.05 and a 52-week high of $45.79. The company has a current ratio of 1.71, a quick ratio of 1.57 and a debt-to-equity ratio of 0.89. The company's 50-day simple moving average is $28.30 and its 200 day simple moving average is $29.78. The firm has a market cap of $3.17 billion, a P/E ratio of -249.50, a PEG ratio of 2.24 and a beta of 2.71.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the company. Barclays assumed coverage on Surgery Partners in a report on Wednesday, March 6th. They issued an "equal weight" rating and a $35.00 price objective for the company. Citigroup decreased their target price on Surgery Partners from $43.00 to $42.00 and set a "buy" rating for the company in a research report on Tuesday, February 27th. Royal Bank of Canada reissued an "outperform" rating and issued a $49.00 target price on shares of Surgery Partners in a research report on Thursday, February 29th. StockNews.com raised Surgery Partners from a "sell" rating to a "hold" rating in a research report on Thursday, March 21st. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and set a $43.00 price objective on shares of Surgery Partners in a research report on Wednesday, April 10th. Two research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat, Surgery Partners presently has a consensus rating of "Moderate Buy" and an average target price of $43.63.

Insiders Place Their Bets

In other Surgery Partners news, CEO Jason Eric Evans sold 4,840 shares of Surgery Partners stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $29.71, for a total value of $143,796.40. Following the completion of the sale, the chief executive officer now owns 459,670 shares of the company's stock, valued at approximately $13,656,795.70. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, insider Bradley R. Owens sold 1,040 shares of the firm's stock in a transaction on Monday, February 12th. The stock was sold at an average price of $35.22, for a total value of $36,628.80. Following the transaction, the insider now directly owns 73,149 shares in the company, valued at approximately $2,576,307.78. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Jason Eric Evans sold 4,840 shares of the firm's stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $29.71, for a total value of $143,796.40. Following the completion of the transaction, the chief executive officer now owns 459,670 shares in the company, valued at $13,656,795.70. The disclosure for this sale can be found here. In the last quarter, insiders sold 18,774 shares of company stock valued at $608,352. Corporate insiders own 2.60% of the company's stock.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.